SITS MOST

Summary

An open, prospective, non-randomised observational study of safety and efficacy of treatment with intravenous rt-PA within 3 hours of onset of acute ischaemic stroke, based on the SITS International Stroke Thrombolysis Register. Performed in European Union countries.